AA
AERI

ALPS Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

ALPS Advisors’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-80,025
Closed -$4.93M – 968
2018
Q3 		$4.93M Buy
80,025
+23,058
+40% +$1.48M 0.03% 164
2018
Q2 		$3.85M Buy
56,967
+6,411
+13% +$359K 0.03% 190
2018
Q1 		$2.74M Buy
50,556
+9,883
+24% +$553K 0.02% 188
2017
Q4 		$2.43M Buy
40,673
+4,883
+14% +$296K 0.02% 183
2017
Q3 		$1.74M Buy
35,790
+3,856
+12% +$210K 0.01% 200
2017
Q2 		$1.68M Buy
31,934
+3,216
+11% +$150K 0.01% 194
2017
Q1 		$1.3M Sell
28,718
-3,362
-10% -$150K 0.01% 199
2016
Q4 		$1.21M Sell
32,080
-3,478
-10% -$132K 0.01% 205
2016
Q3 		$1.34M Sell
35,558
-1,710
-5% -$37.7K 0.01% 207
2016
Q2 		$656K Buy
37,268
+7,618
+26% +$123K 0.01% 222
2016
Q1 		$361K Sell
29,650
-5,082
-15% -$80.4K ﹤0.01% 571
2015
Q4 		$846K Sell
34,732
-5,483
-14% -$128K 0.01% 222
2015
Q3 		$7.13K Buy
40,215
+15,008
+60% +$272K 0.01% 230
2015
Q2 		$445K Buy
25,207
+13,284
+111% +$244K ﹤0.01% 603
2015
Q1 		$374K Buy
+11,923
New +$346K ﹤0.01% 618

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ALPS Advisors's AERI Position: Q4 2018 in Review

ALPS Advisors sold out of Aerie Pharmaceuticals (AERI) in Q4 2018, closing a stake of 80,025 shares — an estimated $4.93M sold.

ALPS Advisors first reported a position in AERI in Q1 2015 and held it in 15 quarters. The position peaked at $4.93M in Q3 2018. 160 funds tracked by Wall St. Rank hold AERI as of Q4 2018.

  • ALPS Advisors reported no remaining Aerie Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • ALPS Advisors sold 80,025 Aerie Pharmaceuticals shares in Q4 2018, an estimated $4.93M.
  • ALPS Advisors first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 15 quarters.
  • ALPS Advisors's Aerie Pharmaceuticals position peaked at $4.93M in Q3 2018.
  • 160 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2018.

Based on ALPS Advisors's 13F filing for Q4 2018, filed 4 Feb 2019.